Less Frequent Colonoscopy After Polyp Removal Could Be the Way to Go, Study Suggests

An interim analysis of an ongoing noninferiority trial, presented at the Digestive Disease Week (DDW) conference in Washington, D.C., indicates that surveillance colonoscopies performed 5 years after the removal of high-risk adenomas are as effective in detecting colorectal cancer (CRC) as those conducted at a shorter 3-year interval. This finding suggests a potential revision to current follow-up protocols for individuals who have undergone adenoma resection, aiming to reduce the frequency of invasive procedures without compromising patient outcomes.

The study in question is a prospective, randomized, noninferiority trial, a robust design for comparing the effectiveness of different medical interventions. Participants are being randomly assigned to either a 3-year or a 5-year colonoscopy surveillance schedule following the removal of adenomas classified as high-risk. High-risk adenomas are characterized by specific features such as larger size (typically >10 mm), a villous component (a histological pattern associated with higher malignant potential), or the presence of high-grade dysplasia (precancerous changes in the cells). These characteristics are known indicators of an increased likelihood for progression to invasive colorectal cancer.

The interim analysis, which has reviewed data from a substantial, though unspecified, number of participants, focuses on the primary endpoint of detecting advanced colorectal neoplasia. This endpoint encompasses both colorectal cancer and advanced adenomas, which are polyps with a high potential to develop into cancer. The researchers reported that the incidence of advanced neoplasia was comparable between the group undergoing 5-year surveillance and the group with 3-year surveillance. This suggests that the extended 5-year interval did not result in a statistically significant increase in the rate of missed cancers or advanced adenomas compared to the more frequent 3-year follow-up.

This research holds considerable significance in the context of current clinical guidelines and the practical implications of frequent colonoscopies. Various gastroenterological societies, such as the American College of Gastroenterology (ACG) and the American Society of Gastrointestinal Endoscopy (ASGE), provide guidelines for colorectal cancer screening and surveillance. These guidelines typically recommend surveillance intervals ranging from 3 to 10 years, contingent upon factors like the number, size, and histological features of polyps previously removed. If the findings of this trial are confirmed upon its completion, a 5-year surveillance interval could offer a substantial benefit by reducing the number of invasive colonoscopies for a significant patient population. This could lead to decreased healthcare expenditures, a lessened burden on patients in terms of discomfort and time off work, and potentially fewer procedural complications, all while maintaining or improving the efficacy of colorectal cancer detection. The trial's ultimate goal is to furnish strong evidence that can inform future updates to clinical practice guidelines and refine strategies for optimizing colorectal cancer screening and surveillance.